Long-term outcomes with abandoning versus extracting sterile leads: A 10-year population-based study

被引:1
作者
Lee, Justin Z. [1 ,2 ,5 ]
Talaei, Fahimeh [1 ]
Tan, Min-Choon [1 ]
Srivathsan, Komandoor [1 ]
Sorajja, Dan [1 ]
Valverde, Arturo [1 ]
Scott, Luis [1 ]
Asirvatham, Samuel J. [3 ]
Kusumoto, Fred [4 ]
Mulpuru, Siva K. [3 ]
Cha, Yong-Mei [3 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, Phoenix, AZ USA
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH USA
[3] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[4] Mayo Clin, Dept Cardiovasc Med, Jacksonville, FL USA
[5] Mayo Clin, Dept Cardiovasc Med, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2024年 / 47卷 / 05期
关键词
cardiovascular implantable electronic devices; lead abandonment; sterile lead; subsequent lead extraction; transvenous lead extraction; CARDIOVERTER-DEFIBRILLATOR IMPLANTATION; EXPERT CONSENSUS STATEMENT; TRICUSPID REGURGITATION; PACEMAKER; TRENDS;
D O I
10.1111/pace.14940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term outcomes of sterile lead management strategies of lead abandonment (LA) or transvenous lead extraction (TLE) remain unclear. Methods: We performed a retrospective study of a population residing in southeastern Minnesota with follow-up at the Mayo Clinic and its health systems. Patients who underwent LA or TLE of sterile leads from January 1, 2000, to January 1, 2011, and had follow-up for at least 10 years or until their death were included. Results: A total of 172 patients were included in the study with 153 patients who underwent LA and 19 who underwent TLE for sterile leads. Indications for subsequent lead extraction arose in 9.1% (n = 14) of patients with initial LA and 5.3% (n = 1) in patients with initial TLE, after an average of 7 years. Moreover, 28.6% of patients in the LA cohort who required subsequent extraction did not proceed with the extraction, and among those who proceeded, 60% had clinical success and 40% had a clinical failure. Subsequent device upgrades or revisions were performed in 18.3% of patients in the LA group and 31.6% in the TLE group, with no significant differences in procedural challenges (5.2% vs. 5.3%). There was no difference in 10-year survival probability among the LA group and the TLE group (p = .64). Conclusion: An initial lead abandonment strategy was associated with more complicated subsequent extraction procedures compared to patients with an initial transvenous lead extraction strategy. However, there was no difference in 10-year survival probability between both lead management approaches.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 23 条
[1]   Tricuspid Regurgitation and Implantable Devices [J].
Al-Bawardy, Rasha ;
Krishnaswamy, Amar ;
Rajeswaran, Jeevanantham ;
Bhargava, Mandeep ;
Wazni, Oussama ;
Wilkoff, Bruce ;
Tuzcu, Emin Murat ;
Martin, David ;
Thomas, James ;
Blackstone, Eugene ;
Kapadia, Samir .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02) :259-266
[2]   2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS [J].
Bongiorni, Maria G. ;
Burri, Haran ;
Deharo, Jean C. ;
Starck, Christoph ;
Kennergren, Charles ;
Saghy, Laszlo ;
Rao, Archana ;
Tascini, Carlo ;
Lever, Nigel ;
Kutarski, Andrzej ;
Lozano, Ignacio Fernandez ;
Strathmore, Neil ;
Costa, Roberto ;
Epstein, Laurence ;
Love, Charles ;
Blomstrom-Lundqvist, Carina ;
Fauchier, Laurent ;
Defaye, Pascal ;
Arnar, David O. ;
Klug, Didier ;
Boveda, Serge ;
Nielsen, Jens Cosedis ;
Boriani, Giuseppe ;
Zhang, Shu ;
Martin, Andrew Paul ;
Prutkin, Jordan M. ;
de Zuloaga, Claudio .
EUROPACE, 2018, 20 (07) :1217-+
[3]   Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996 [J].
Byrd, CL ;
Wilkoff, BL ;
Love, CJ ;
Sellers, TD ;
Turk, KT ;
Reeves, R ;
Young, R ;
Crevey, B ;
Kutalek, SP ;
Freedman, R ;
Friedman, R ;
Trantham, J ;
Watts, M ;
Schutzman, J ;
Oren, J ;
Wilson, J ;
Gold, F ;
Fearnot, NE ;
Van Zandt, HJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (09) :1348-1357
[4]  
da Costa SSD, 2002, PACE, V25, P1301
[5]   Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades A Population-Based Study [J].
Dai, Mingyan ;
Cai, Cheng ;
Vaibhav, Vaidya ;
Sohail, M. Rizwan ;
Hayes, David L. ;
Hodge, David O. ;
Tian, Ying ;
Asirvatham, Roshini ;
Cochuyt, Jordan J. ;
Huang, Congxin ;
Friedman, Paul A. ;
Cha, Yong-Mei .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (09) :1071-1080
[6]   Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads [J].
Delling, Francesca N. ;
Hassan, Zena K. ;
Piatkowski, Gail ;
Tsao, Connie W. ;
Rajabali, Alefiyah ;
Markson, Lawrence J. ;
Zimetbaum, Peter J. ;
Manning, Warren J. ;
Chang, James D. ;
Mukamal, Kenneth J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) :988-992
[7]   Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009 Increasing Complexity of Patients and Procedures [J].
Greenspon, Arnold J. ;
Patel, Jasmine D. ;
Lau, Edmund ;
Ochoa, Jorge A. ;
Frisch, Daniel R. ;
Ho, Reginald T. ;
Pavri, Behzad B. ;
Kurtz, Steven M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (16) :1540-1545
[8]   Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade [J].
Haghjoo, Majid ;
Nikoo, Mohammad Hossein ;
Fazelifar, Amir Farjam ;
Alizadeh, Abolfath ;
Emkanjoo, Zahra ;
Sadr-Ameli, Mohammad Ali .
EUROPACE, 2007, 9 (05) :328-332
[9]  
Hussein Ayman A, 2017, JACC Clin Electrophysiol, V3, P1, DOI 10.1016/j.jacep.2016.06.009
[10]   Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study [J].
Korkeila, Petri ;
Ylitalo, Antti ;
Koistinen, Juhani ;
Airaksinen, K. E. Juhani .
ANNALS OF MEDICINE, 2009, 41 (03) :216-223